Home
Market Capitalization of Wockhardt Ltd

Wockhardt Ltd
NSE: WOCKPHARMA
Market Cap
Key Highlights
- The Market Cap of Wockhardt Ltd is ₹ 21375 crore as of 21 Feb 25 .
- The Latest Trading Price of Wockhardt Ltd is ₹ 1315 as of 21 Feb 15:30 .
- The Dividend Payouts of Wockhardt Ltd changed from ₹ 5 on Feb 17, 2014 to ₹ 10 on Nov 17, 2016 . This represents a CAGR of 25.99% over 3 years.

Wockhardt Ltd
NSE: WOCKPHARMA
Share Price
Market Price of Wockhardt Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1315.65 |
20 Feb 2025 | 1382.5 |
19 Feb 2025 | 1367.7 |
18 Feb 2025 | 1358.7 |
17 Feb 2025 | 1410.95 |
14 Feb 2025 | 1382.75 |
13 Feb 2025 | 1439.35 |
12 Feb 2025 | 1515.1 |
11 Feb 2025 | 1446.3 |
10 Feb 2025 | 1522.4 |
SWOT Analysis Of Wockhardt Ltd
BlinkX Score for Wockhardt Ltd
Asset Value vs Market Value of Wockhardt Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Wockhardt Ltd
Historical P/E Ratio of Wockhardt Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Wockhardt Ltd
Historical Revenue of Wockhardt Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Wockhardt Ltd
Historical EBITDA of Wockhardt Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Wockhardt Ltd
Historical Net Profit of Wockhardt Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Wockhardt Ltd
Historical Dividend Payouts of Wockhardt Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Wockhardt Ltd
About Wockhardt Ltd
- Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
- The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
- It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
- It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
- Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.
Wockhardt Ltd News Hub
Wockhardt reports consolidated net loss of Rs 14.00 crore in the June 2024 quarter
Net Loss of Wockhardt reported to Rs 14.00 crore in the quarter ended June 2024 as against net loss
Read more
09 Aug 24
Wockhardt to table results
Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered by
Read more
08 Aug 24
Wockhardt allots 8,610 equity shares under ESOS
Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotment, the pa
Read more
26 Aug 24
Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections
In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has successfully
Read more
19 Sept 24